Baird Financial Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.9K | Hold |
21,393
| – | – | ﹤0.01% | 1751 |
|
|
2025
Q1 | $41.1K | Buy |
21,393
+4,000
| +23% | +$7.68K | ﹤0.01% | 1740 |
|
|
2024
Q4 | $33K | Hold |
17,393
| – | – | ﹤0.01% | 1741 |
|
|
2024
Q3 | $23K | Hold |
17,393
| – | – | ﹤0.01% | 1741 |
|
|
2024
Q2 | $17.7K | Buy |
17,393
+1,650
| +10% | +$1.68K | ﹤0.01% | 1749 |
|
|
2024
Q1 | $28.8K | Buy |
15,743
+3,000
| +24% | +$5.49K | ﹤0.01% | 1740 |
|
|
2023
Q4 | $15.8K | Hold |
12,743
| – | – | ﹤0.01% | 1700 |
|
|
2023
Q3 | $14.5K | Buy |
+12,743
| New | +$14.5K | ﹤0.01% | 1701 |
|
|
2017
Q4 | – | Sell |
-10,285
| Closed | -$202K | – | 1259 |
|
|
2017
Q3 | $202K | Buy |
+10,285
| New | +$202K | ﹤0.01% | 1179 |
|